NCT00448786View on ClinicalTrials.gov

Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

March 31, 2009

Conditions
Solid Tumors
Interventions
DRUG

AMG 706

Arm B - AMG 706 75 mg BID 2-weeks on and 1-week off

DRUG

AMG 706

Arm C - 75 mg BID 5-days on, 2-days off

DRUG

AMG 706

AMG 706 125 mg daily continuously (Arm A)

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00448786 - Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors | Biotech Hunter | Biotech Hunter